Here are four things to know:
1. The final products have been examined under scanning electron microscopy to confirm the integrity and validity of the 3D printing method.
2. The company plans to use the 3D printing method for its proprietary silicon nitride devices. The final products also achieved similar theoretical density and microstructure attributes to the traditionally manufactured silicon nitride fusion devices.
3. The 3D printing process is essentially binderless and a device can be completely sintered in less than 24 hours.
4. Amedica is focused on the development and application of interbody implants manufactured with medical-grade silicon nitride ceramic.
More articles on devices:
Cervical total disc replacement device market to hit $1.8B — 4 notes
Lakeway Regional Medical Center now a CarboClear Pedicle Screw System study site: 5 observations
Magnesium Development Company raises $1M for new orthopedic device alloy: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
